Trillium Therapeutics (NASDAQ: TRIL) announced that it is offering to sell US$50,000,000 of common shares and preferred shares in an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE